US0311621009 - Common Stock - After market: 253.65 0 (0%)
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, Jan. 31, 2023,...
Horizon Pharmaceuticals (HZNP) dropped on a report that Sen. Elizabeth Warrenhas concerns about Amgen's (AMGN) plan to buy Horizon Therapeutics (HZNP) and Indivior plan to acquire Opiant
Horizon Pharmaceuticals (HZNP) dropped on a report that Sen. Elizabeth Warrenhas concerns about Amgens (AMGN) plan to buy Horizon Therapeutics (HZNP) and Indivior plan to acquire Opiant
Developing new products will be key to the success of both of these biotech leaders.
The 2023 Dogs of the Dow feature several stocks investors should consider for their income portfolios. Here are the top five picks.
These dividend stocks can deliver both downside protection and capital appreciation.
Look for the top companies in businesses the world perpetually needs.
Three years ago, drugmakers and laboratories around the world responded to the pandemic with Covid-19 vaccines. Now that the urgency has faded, they’re collectively turning attention to an older pandemic: obesity.
A panel of the European Medicine Agency ((EMA)) issued a positive opinion on a self-administration option of Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire.The decision of...
The Supplant Co. has trademarked a method of turning discarded oat hulls into high-protein starch.
Meet the Dogs of the S&P.
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
/PRNewswire/ -- Amgen (NASDAQ:AMGN) and BioLabs LA at The Lundquist Institute today announced that Nammi Therapeutics has been awarded the third Amgen Golden...
CVS Health Corp., the largest prescription benefits provider in the US, is still deciding on its approach to covering one of the world’s best-selling drugs, Humira, as a competing version is set to hit the market at the end of this month.
Considering their potential, all three stocks look like good opportunities today.
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 J.P. Morgan Healthcare Conference at 6:45 p.m. ET on Monday, January 9, 2023. Robert A. Bradway,...
The Dow crushed the Nasdaq in 2022, but that's no guarantee of a lasting trend.
After a tumultuous year, this simple strategy that outperformed sagging markets might be just what you're looking for.
Nothing is more reassuring to an income investor than a boost to the dividend.